Analytics

Mount Sinai, ARC Innovation Center and Nvidia are collaborating to build AI models that can decode the human genome in order to accelerate breakthroughs in genetic therapies and personalized medicine.

SpotitEarly CEO Shlomi Madar explains how the company uses dogs' superior sense of smell, combined with sensors and AI, for early detection of lung, prostate, colorectal and breast cancers in patients' breath samples.

GE HealthCare's Sergio Calvo explains how theranostics uses molecular imaging to confirm a cancer target, deliver radiation therapy directly to tumor cells, which helps protect healthy tissue, and track post-therapy results.

Michael Clark, president of OnPoint Healthcare Partners, says healthcare practices must keep humans in the loop to monitor AI agents' ability to complete tasks as well as to evaluate agents' final output for accuracy.

Venture studio AION Labs' CEO Mati Gill says AION unites competing pharma companies in developing AI projects via a federated data platform, enabling pre-competitive collaboration while allowing each entity to isolate its own data.

Epic's Trevor Berceau and Sutter Health's Dr. Richard Milani discuss how their organizations linked FDA-approved monitoring devices directly to MyChart to let chronic care patients send data easily to their charts between visits.

Atropos Health CEO Brigham Hyde says the company's AI Evidence Agent integrates directly into Microsoft Teams to provide tumor boards with concise, citation-backed guidance tailored to patient data in real time.